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hepatitis B patients. Long-term outcomes were better in
those subjects with HBVDNA 105 copies/mL at Week 40.
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Viruses are one of the major causes of acute respiratory
tract illnesses (ARTIs) throughout the world. The classical
common viruses causing ARTIs include inﬂuenza virus
(IFV), parainﬂuenza viruses 1 4 (PIVs), enterovirus (EV),
human rhinovirus (HRV), respiratory syncytial virus (RSV),
adenovirus (AdV), and human coronavirus (HCoV) 229E and
OC43. The improvement of molecular detection techniques
has resulted in the recent identiﬁcation of several
new respiratory viruses, such as human metapneumovirus
(hMPV), novel strains of coronaviruses (SARS-CoV, HCoV-
NL63 and HCoV-HKU1), human bocavirus (HBoV), and
novel polyomaviruses (WUPyV and KIPyV). The frequent
emergency of severe diseases caused by respiratory viruses
has made viral ARTIs a global health challenge with high-
priority. The studies on the immunological features by
antigenomics (including epitomics) analysis will provide
basis for monitoring epidemic patterns, investigating the
epidemiology and developing diagnosis and vaccines. We
have developed a comprehensive platform to express and
purify the major antigens encoded by IFVs, PIVs, RSV, hMPV,
HCoV, AdV, etc. The puriﬁed products have been used to the
study of respiratory virus antigenome and epitome, which
will provide insight into the immunological properties of the
viruses.
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The vaccination program is a reliable strategy in controlling
the prevalence of inﬂuenza epidemics. Due to the frequent
variation, the recommended inﬂuenza virus strains for
vaccine production have to be changed every year based
on the surveillance data. Because the preparation of virus
seed lots suitable for vaccine production is time-consuming,
a simple approach to obtain the vaccine strains rapidly has
been a priority topic in inﬂuenza vaccine research and
development. The emergency of reverse genetic system of
inﬂuenza virus allows the rapid production of inﬂuenza virus
from cloned cDNAs and has been becoming a encouraging
alternative approach for inﬂuenza virus seed generation.
However, current reverse genetics techniques to rescue
inﬂuenza viruses are based on bidirectional RNA Pol I Pol II
transcription system, which can not meet to the need of
human vaccine production because of low yield. Here we
report improved the RNA polymerase II (pol II) promoter
of mRNA synthesis have led to a signiﬁcant higher-yielding
vaccine strain production. These improvements pave the
way for the reproducible generation of inﬂuenza virus
vaccine strain and may be applicable to other reverse
genetics systems.
